ObsEva SF KOL Lunch

San Francisco, November 9, 2017
RSVP for Event / Log Back in

Additional menu options can be found in the menu bar on the left or at the top.

ObsEva [OBSV] US$560 MM MCap
Ob­sE­va is a clin­i­cal-stage bio­phar­ma­ceu­ti­cal com­pany fo­cused on the clin­i­cal de­vel­op­ment and com­mer­cial­iza­tion of nov­el ther­a­peu­tics for se­ri­ous con­di­tions that com­pro­mise a wo­m­an's re­pro­duc­tive... [more in­for­ma­tion]